
FDA shuffles top drug, biologics leaders in latest shakeup
The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators, days after the departure of former commissioner Marty Makary.

The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators, days after the departure of former commissioner Marty Makary.

US-Präsident Donald Trump hat den Abgang des FDA-Chefs Marty Makary bekanntgegeben. Makary war vor einem Jahr mit dem Versprechen von Reformen angetreten, aber wegen seiner Haltung zu Abtreibungspillen und E-Zigaretten in die Kritik geraten.

Marty Makary resigned as FDA Commissioner after White House pressure, particularly over disagreements on flavored e-cigarettes and mifepristone safety reviews, with Kyle Diamantas named as acting commissioner.

Dr. Marty Makary resigned as FDA commissioner amid controversy and internal dysfunction, to be replaced by Kyle Diamantas as acting commissioner

La salida de Marty Makary supone un nuevo golpe en la controvertida gestión de Robert Kennedy como secretario de Salud

Dr. Marty Makary to resign as FDA commissioner amid tumultuous tenure and pressure from the White House over flavored e-cigarette sales

Dr. Marty Makary resigned as FDA Commissioner after 13 months, marked by controversy over vaccine approvals, abortion drug policies, and regulatory clashes. President Trump praised Makary and announced Kyle Diamantas as acting head.

Critiqué par les deux bords politiques pour sa gestion de plusieurs dossiers sensibles, ce chirurgien en poste depuis un an aurait présenté sa démission selon des médias américains.

US Food and Drug Commissioner Marty Makary resigned on Tuesday, President Donald Trump said, the latest leadership change at the federal health department which comes after weeks of public speculation and a mounting pressure campaign. FDA Deputy Commissioner for Food Kyle Diamantas will lead the agency in an acting capacity, according to two sources familiar with the situation. Politico first reported the development. “Marty is a terrific guy, but he’s going to go on and he’s going to lead a...

Marty Makary, capo della FDA, si dimette dopo speculazioni su possibili scontri con Trump su aborto e sigarette elettroniche.

The plan isn't final and could change, but his ouster would be no surprise.

U.S. Food and Drug Administration Commissioner Marty Makary, under pressure, defends himself in an interview with CNBC's David Faber.